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Abstract
This study presents a novel method to visualize protein aggregate and particle formation data to
rapidly evaluate the effect of solution and stress conditions on the physical stability of an IgG1
monoclonal antibody (mAb). Radar chart arrays were designed so that hundreds of Microflow
Digital Imaging (MFI) solution measurements, evaluating different mAb formulations under
varying stresses, could be presented in a single figure with minimal loss of data resolution. These
MFI radar charts show measured changes in subvisible particle number, size and morphology
distribution as a change in the shape of polygons. Radar charts were also created to visualize mAb
aggregate and particle formation across a wide size range by combining data sets from size
exclusion chromatography (SEC), Archimedes resonant mass measurements, and MFI. We found
that the environmental/mechanical stress condition (e.g., heat vs. agitation) was the most
important factor in influencing the particle size and morphology distribution with this IgG1 mAb.
Additionally, the presence of NaCl exhibited a pH and stress dependent behavior resulting in
promotion or inhibition mAb particle formation. This data visualization technique provides a
comprehensive analysis of the aggregation tendencies of this IgG1 mAb in different formulations
with varying stresses as measured by different analytical techniques.
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Introduction
Improving our basic understanding of protein aggregate and particle formation pathways
during the manufacturing and storage of therapeutic protein candidates is of increasing
interest to protein formulation scientists and regulators alike. This interest primarily arises
from the potential ability of these particles to induce an unwanted, humoral immune
response resulting in the production of anti-drug antibodies that reduce the efficacy of the
administered therapy.1 Previous investigators have shown that particles generated by
different stresses vary in average size, shape, concentration, transparency, and chemical
modifications, however, the physicochemical properties of a protein particle that potentially
elicit an immune response remain elusive.2–4 The immunogenic potential of particle
subpopulations is difficult to study because separating and isolating species from a highly
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heterogeneous population, while maintaining their structural integrity, is technically
challenging.4 Additionally, sample handling must be minimized during particle
characterization to preserve the integrity of the measured particle populations.5,6 Because of
these challenges, formulation development strategies for protein therapeutics are
increasingly focused on reducing the number of submicron and subvisible particle
degradants that form during manufacturing and storage.7 The formation of proteinaceous
particles can be reduced by increasing both the conformational and colloidal stability of the
protein in solution as well as by decreasing the number of nucleating species.8 Non-native
aggregation is often initiated by partially unfolded or misfolded monomers that associate if
there is a favorable change in the free energy of the system.9–14 Certain anions (e.g.,
chloride) preferentially accumulate on the surface of proteins and can influence both the
conformational and colloidal stability of proteins in solution.15,16
Multiple analytical instruments are needed to measure the full range of aggregates and
particles in solution because no single technique is currently capable of providing an
accurate, quantitative description of the entire aggregation profile of a protein solution.17–20
Subvisible and submicron are terms used to classify particles that are 1–100 µm and 0.1 to
<1 µm, respectively.7 Microflow digital imaging (MFI) has become a popular technique to
characterize subvisible particles and has been used to study particle formation in monoclonal
antibody formulations.21–24 MFI captures digital images of particles from a solution passing
through a flow cell and uses algorithms to measure a wide variety of parameters including,
but not limited to, equivalent circular diameter, concentration, counts, circularity, aspect
ratio, and intensity. These parameters provide an advantage over other subvisible particle
counting techniques because morphological filters can be used to discriminate between
proteinaceous particles and non-proteinaceous silicone oil droplets or air bubbles.25 A
limitation of MFI, however, is the possible undercounting of particles that have a refractive
index similar to that of the solvent.26 This experimental artifact can be partially corrected
through the proper use of the optimize illumination function.22,26,27 The Archimedes
Particle Metrology System uses the principle of resonant mass measurement (RMM) to
measure the buoyant mass of particles from a solution passing through a suspended
microchannel resonator (SMR). When equipped with a Hi-Q microsensor, the Archimedes is
able to measure submicron particles from 200 nm to subvisible particles <5 µm in equivalent
spherical diameter. Additionally, RMM has been used to study submicron particle as low as
~104 particles/ml in a monoclonal antibody formulation.28 Weinbuch et al. describes a
comparative analysis of MFI and RMM measurements and includes more discussion of the
measurement principles and limitations of both instruments.29 Both RMM and MFI provide
high resolution particle size and concentration data by counting individual particles, but the
large quantity of data produced makes it challenging to compare trends across multiple data
sets.
Data visualization methods have been developed to aid in the formulation development of
protein-based therapeutic drugs and vaccines. The empirical phase diagram (EPD) visualizes
macromolecule structural changes as a shift in colors as a function of environmental stresses
(e.g., temperature and solution pH). The EPD visually summarizes biophysical stability data
from multiple techniques that have been reduced in dimensionality through principle
components analysis.30,31 There are several reports in which the EPD has been used to
visualize changes in mAb conformational stability and dynamics.32–34 Additional data
visualization methods have more recently been developed to examine protein stability data
including radar chart analysis and comparative signature diagrams.35,36 Radar charts have
the advantage of displaying multidimensional data without truncating the data or using
statistical methods such as principle components analysis.
Kalonia et al. Page 2













In this report, we apply radar chart array analysis to compare multiple, large data sets from
different analytical methods to determine the effect of formulation variables on the nature of
IgG1 mAb aggregates and particles generated through different stress conditions. First, we
assess the effect of solution pH and NaCl on the concentration, size, and formation kinetics
of subvisible particles, measured by MFI, created due to stirring and shaking of the mAb
solutions. Additionally, we use radar chart array analysis to evaluate how IgG1 mAb particle
morphology, i.e., the particle’s aspect ratio (a measure of elongation) and intensity (a
measure of particle transparency), are affected by formulation conditions. Lastly, we
examine the potential of radar chart analysis to visualize formation of the particles and
aggregates across the entire size profile, from subvisible and submicron sized particles to
small soluble aggregates as measured by MFI, RMM, and size exclusion high performance
liquid chromatography (SE-HPLC), respectively.
Experimental Procedures
Materials and Sample Preparation
An IgG1 mAb (pI ~9) was supplied by Janssen Biotech Inc. (Horsham, PA) at ~40 mg/ml.
Working mAb solutions were made by diluting the stock solution into 20 mM citrate-
phosphate buffer to a final protein concentration of 1.0 mg/ml. Individual samples were
prepared at pH 4.0, 6.0 and 8.0 and NaCl concentrations of 0, 0.15, and 1.0 M. These
working solutions (3 mL) were prepared in glass vials (37.7×16.75 mm) from Schott
(Lebanon, PA) and capped with 20 mm lyophilization vial stoppers (West Pharmaceutical
Services, Exton, PA).
Generations of Aggregates
Heat stressed aggregates were generated by incubating samples at 65°C for 10, 120, and 240
min. Stirred stressed aggregates were generated by stirring samples with teflon coated micro
spinbars (Fisher) for 10, 120, and 240 min. The stirring speed was adjusted to setting 5 on a
Pierce Reacti-Therm III from Thermo Scientific (West Palm Beach, FL). Shaking stressed
protein aggregates were made by shaking samples side to side at 300 RPM for 10, 120, and
240 min using a HS 260 shaker from IKA Works Inc. (Wilmington, NC). Stress conditions
were selected based on separate studies examining the effect of environmental stresses on
the extent of aggregate and particle formation with same IgG1 mAb (Telikepalli et al,
submitted).
Differential Scanning Calorimetry
DSC was performed with 1.0 mg/ml protein samples, prior to stress exposure, using a high
throughput capillary VP-DSC (MicroCal, Piscataway, NJ). Thermograms were obtained by
scanning from 10° to 90°C at a rate of 60°C/hr as described previously.37 Tm values were
obtained by iteratively fitting the thermogram to a non-2-state model for unfolding. To
values were obtained by determining the point at which a specific interpolated tangent line
intersects the horizontal axis.
Extrinsic Fluorescence Spectroscopy
IgG1 mAb samples were diluted to 0.1 mg/ml in their corresponding buffers and a 20 molar
excess of 1-anilinonaphthalene-8-sulfonate (ANS, Sigma) was added. The fluorescence
emission was measured using a QM-40 spectrofluorometer from Photon Technology
International (Birmingham, NJ) as described previously.21
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Size-exclusion High Performance Liquid Chromatography
A Tosoh Bioscience TSKgel G3000SWx1 stainless steel column (San Francisco, CA) along
with the corresponding guard column (TSKgel SWxl guard column) operated at 30°C was
used in all experiments. A Shimadzu Prominence UFLC HPLC system (Kyoto, Japan)
connected to a diode array detector was used. Twenty five µL of each sample were injected
into a column that was equilibrated with at least 10 column volumes of 200 mM sodium
phosphate buffer (pH 6.8). The flow rate was 0.7 mL/min and the measurement time was 30
minutes. LC Solution software was used for data analysis and peak integration. Percent total
area loss (compared to time=0), percent monomer loss, and percent soluble aggregate in
solution were reported as described previously in Bond et al., which also details the column
conditioning procedure and column performance/recovery for characterizing protein
aggregates.38
Resonant Mass Measurement
An Archimedes Particle Metrology System (Affinity Biosensors, Santa Barbara, CA) was
used to quantify submicron and small subvisible particles from 0.275 to 1.85 µm. A Hi-Q
micro sensor, calibrated using 1.03 µm polystyrene beads (Affinity Biosensors), was used
for all measurements. Reference solutions of 1:20 D2O:H2O or pure H2O were used
depending upon the solution density of the sample being measured. Prior to daily
measurements, the accuracy of the Hi-Q microsensor was tested using the 1.03 µm bead
standard. Before each measurement, the sensor and the micro tubing, was rinsed with 2%
PCC-54 detergent, by applying high pressure on the sample and reference vials to clean the
bypass channels. In addition to the high pressure applied to the sample and reference vials,
low pressure was also applied to the sample waste vial to induce a flow to rinse the sensor
with 2% PCC-54 detergent. This process was applied until a clean frequency trace was
achieved. The sensor was then loaded with particle free water and two “sneeze” operations
were performed. The sample was loaded for 30 s, and a stop trigger of 200 particles or 30
min measurement time was used. The limit of detection was empirically determined (0.035
Hz) and used throughout the study. The density value for the mAb was estimated at 1.41g/
ml based on protein molecular weight.39
Microflow digital imaging
A DPA-4200 flow microscope (Protein Simple, Santa Clara, CA) was used to capture digital
images of subvisible particles with ECD from 2–70 µm. Before each measurement, the flow
cell was primed in the following manner: particle free water was flushed through the flow
cell at the maximum flow rate until the flow cell was observed to be particle free for at least
30 s. The optimize illumination function was then used to ensure the proper level of solvent
illumination. Samples underwent the minimal required amount of sample handling prior to
measurement and were degassed by exposure to a vacuum chamber for 10 min. To prevent
clogging of the flow cell, samples containing approximately 50 or more visible particles
(observed through visual inspection) were set aside for 30 min to allow the largest particles
to settle. Samples with particle concentrations over the limit of quantitation (900,000 counts/
ml)22 were diluted and the results were corrected for the dilution factor (samples subjected
to 240 min of stirring were diluted 1:3, and samples stressed for ≥120 min by heat were
diluted 1:10). Particle statistics were generated using MFI View Analysis Suite (MVAS)
version 1.3 (Protein Simple, Santa Clara, CA). Each MFI measurement was separated into
five subpopulations based upon particle equivalent circular diameter (ECD); 2≤x<5,
5≤x<10, 10≤x<25, 25≤x<50, and 50≤x<70 µm.
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Radar charts were generated using software developed in our laboratory (MiddaughSuite) as
described previously36. This report is, however, the first time that radar chart arrays have
been applied to protein aggregation and particle formation data sets from MFI, RMM and
SEC. To create the MFI particle number and size range radar charts, particle concentration
data, obtained from analysis using MVAS 1.3 software described above, were pre-processed
by calculating the mean, standard deviation, and mean minus standard deviation (m−SD) for
the five particle size populations listed in the previous section. The mean and m−SD values
were then uploaded to MiddaughSuite software. The radar charts were set to a log scale and
each axis was defined to have a minimum of 10 and a maximum of 1,000,000 particles.
Radar charts were generated for both the mean and the m−SD values and then precisely
superimposed using pixel alignment in Adobe Photoshop CS6 (Adobe Systems, San Jose,
CA). The purpose of superimposing the two radar charts was to include an indication of
error for n=3 replicate experiments because particle measurements are often highly variable.
The m−SD was chosen because m+SD values would be hard to visualize because positive
error bars appear smaller on a log scale.
Particle morphology radar charts were created using the average mean intensity and aspect
ratio values for each of the five particle size populations (obtained through the filter
manager tool in MVAS 1.3). These data were pre-processed and the mean and m+SD values
were uploaded to MiddaughSuite. The axes of this radar chart were set to an inverted linear
scale and each axis was defined to have a minimum value of 0.35 and a maximum of 0.85.
Axes with an insufficient number of particles (empirically determined to be < 25 counted)
were highlighted with a light red background color. The mean and the m+SD particle
morphology radar charts were also superimposed using Adobe Photoshop to indicate
variability between n=3 measurements. The m+SD were used to maintain the consistency of
radar chart interpretation because the morphology radar chart arrays use an inverted linear
axis.
To create the “multiple instruments” radar chart, data from SEC, RMM, and MFI were
preprocessed to obtain the mean and the m−SD for each condition. The data were then
uploaded to MiddaughSuite and each axis was highlighted with a background color
according its scale. Axes 1 and 2, corresponding to total area loss and monomer loss were
set to an inverted linear scale between 0 and 100%. Axis 3, the soluble aggregate content,
was set to a linear scale between 0 and 25%. Axes 4–6, representing submicron and small
subvisible particle concentrations between 0.275 and 1.85 µm were set to a log scale with a
minimum value of 104 and a maximum value of 109 particles (approximate limit of
quantitation for the Archimedes). Lastly, axes 7–9, representing subvisible particles from 2–
70 µm, were set to a log scale with a minimum of 100 and a maximum of 107 particles. The
mean and m−SD radar charts were generated and superimposed using Adobe Photoshop to
indicate error between the n=3 measurements.
Results
Conformational stability of IgG1 mAb vs. solution pH and NaCl concentration
Prior to examining the effect of formulation variables on particle formation, differential
scanning calorimetry was used to study the relative conformational stability of the IgG1
mAb in solutions with varying pH and NaCl concentrations. For example, at pH 4, three
thermal melting events were observed at 56.1, 70.7, and 72.6 °C, which are referred to as
Tm1, Tm2, and Tm3, respectively (See Supplemental Figure S1). The effects of solution pH
and NaCl on the observed Tm values for the mAb are summarized in Table 1. mAb
solutions at pH 4 had the lowest thermal melting value (and onset temperatures) while the
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addition of 0.15 and 1 M NaCl to the pH 4 solutions caused further reductions in melting
and onset temperatures (Table 1). At pH 6 and 8 with no NaCl, only Tm2 and Tm3 were
reproducibly detected. Addition of 0.15 M NaCl appeared to slightly lower the melting and
onset temperatures, and the addition of 1 M NaCl resulted in detection of Tm1. In addition,
fluorescence measurements using ANS as an extrinsic probe were used to determine if
solution pH and NaCl concentration influenced ANS interactions with hydrophobic surfaces
within the mAb (or potentially between mAbs). No major differences in ANS fluorescence
intensity were observed in the various mAb solutions described above suggesting no major
alterations of mAb’s overall tertiary structure (or self-associations) across the pH range of
4–8 and NaCl concentrations of 0 to 1M (data not shown).
Radar chart analysis of effects of solution pH, NaCl concentration, and stress on IgG1
mAb particle formation as measured by MFI
Particle number and size—Radar Charts were initially constructed to visualize various
data sets of subvisible particle formation as obtained by MFI with an IgG1 mAb under
different formulation conditions. First, we present some generic MFI data to demonstrate
how to interpret a radar chart. Figure 1A shows a commonly used graphical representation
of generic MFI data from one experimental condition, i.e., a histogram of particle
concentration (log scale) as function of particle size (grouped together in different size bins).
Figure 1B shows the same MFI data in the form of a radar chart. The numbered axes of the
radar chart correspond to the same numbered size bins on the histogram (e.g., number one
refers to particle size bin 2–5 microns in both Figures 1A and 1B). The axes of radar charts
are linearly connected so that the data set can be visualized as a polygon. In addition,
particle concentration is displayed in this radar chart using concentric rings positioned from
the center to the edge of the circle. For example, as shown in Figure 1C, each ring shows a
ten-fold increase in particle concentration.
In Figure 2, radar chart analysis was used to elucidate the effect of varying solution pH,
NaCl concentration, and stress conditions on the kinetics of subvisible particle formation
(number and the size distribution as measured by MFI) for an IgG1 mAb. Prior to stress, a
low number (i.e., 100 to 3,000) subvisible particles were detected in the various protein
samples with samples at pH 4 having fewer particles than pH 6 regardless of the NaCl
concentration. After 10 min of shaking stress (left panel of Figure 2), more than 5,000
particles (2–25 µm) had formed at pH 4 with no added NaCl. Samples containing 0.15 M
NaCl formed particles at a similar rate, however, ~50 particles from 25–50 µm had also
formed. Samples in the presence of 1 M NaCl had the highest particle concentration in size
range of 2–25 µm as well as >100 particles/ml from 25–50 µm. The concentration of
subvisible particles, generated through shaking, increased over the time of shaking with
increased values noted at 120 min. Particle formation decelerated after 120 min (no longer
forming at a logarithmic rate) with the 240 min shaking sample showing similar particle
concentrations and size distributions across the pH and NaCl conditions examined. The
presence of 1 M NaCl had a more pronounced effect on IgG1 mAb samples at pH 4 that
were shaken for more than 2 h since an average of 10,000 particles from 25–50 µm and
1,000 particles from 50–70 µm had formed. In general, the presence of 1 M NaCl at pH 4, 6
or 8 caused larger subvisible particles to form when these protein samples were shaken
(Figure 2, left panel and Supplemental Figure S1).
The IgG1 mAb samples stirred at pH 4 resulted in an entirely different subvisible particle
distribution, compared to shaking under the same solution conditions (Figure 2, middle
panel). For example, particles generated from stirring stress tended to be primarily 2–25 µm
in size. After 10 min of stirring, samples with 0 M NaCl had the least amount of subvisible
particles, 0.15 M NaCl had ~104 particles/ml, and 1 M NaCl had >104 particles. The
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concentration of small particles noticeably increased between 2 and 4 h of stirring. After 4 h
of stirring, for IgG1 mAb samples with 1 M NaCl, the most subvisible particles (> 106
particles/ml from 2–5 µm) were formed, while samples with 0.15 M NaCl formed ~300,000
particles/ml from 2–5 µm and samples with no NaCl formed <50,000 particles/ml (Figure 2,
middle panel).
Samples stirred at pH 6 (Figure 2, right panel) and pH 8 (Supplemental Figure S2, right
panel) exhibited very different behaviors in terms of the effect of NaCl on particle formation
compared to pH 4. Samples at pH 6 in the absence of NaCl had the highest concentration of
subvisible particles over 4 h (particle concentrations >106 particles/ml). In contrast, the
presence 1 M NaCl greatly reduced the concentration of subvisible particles to ~50,000/ml.
At pH 8, the presence of either 0.15 or 1M NaCl greatly reduced the concentration of
subvisible particles for IgG1 mAb samples stirred for 2 and 4 h (Supplemental Figure S2).
Particle Morphology—Representative particle images captured by MFI demonstrate
formation of low, medium, and high aspect ratio/intensity valued protein particles in the
IgG1 mAb solutions depending on the formulation and stress (Figure 3). Model ellipses that
correspond to particle aspect ratio values are also presented as a simplified method to
visualize particle elongation (i.e., aspect ratio). We present some MFI data to demonstrate
how to interpret a radar chart for particle morphology. In Figure 4A, these data are presented
in a manner similar to other reports with published MFI morphological data.40 Figure 4A
shows scatter plots (for the first 3,000 particles counted by MFI, n=1) of particle size vs. a
morphological parameter, one plot for particle aspect ratio and the other for particle
intensity. Morphological data from additional particles cannot be added to these scatter plots
since resolution would be lost as additional data points merge into one continuous color (not
shown). In contrast, the aspect ratio and intensity values from the same experiment, but this
time using the entire, complete data set (>200,000 particles/ml, n =3) are presented as an
radar chart (Figure 4B) showing particle size vs. morphological parameter, using a scale for
the morphology parameters as shown in Figure 4C (i.e., aspect ratio or intensity/1000).
Regions shaded in light red in the radar charts in Figure 4B denote insufficient particles
were present in the samples (empirically defined as < 25 particles as measured by MFI) to
effectively compare the effect NaCl, pH, and stress on particle morphology. One reason this
was done was so that the few subvisible particles present at time zero did not affect the radar
chart analysis of the morphological properties of particles formed from stress and solution
conditions over time.
As an example, radar chart analysis of MFI particle morphological parameters are shown for
IgG1 mAb samples stressed for 4 h with varying pH, NaCl, and stress conditions (Figure 5).
As shown on the left panel, the average particle aspect ratio and intensity values did not
change with NaCl concentration when samples were stirred for 4 h at pH 4. As another
example, the addition of 1 M NaCl had a profound effect on particle morphology when the
samples were subjected to 4 h of shaking at pH 4 and 8. When the mAb samples were
shaken at pH 4 (Figure 5, middle panel), the presence 1 M NaCl caused the average aspect
ratio of all size ranges in the particle distribution to decrease (i.e., the particle elongation
increases). Particles larger than 25 µm had an average aspect ratio of less than 0.35 (refer to
the ellipse models presented in Figure 3). Additionally, the intensity of subvisible particles
in the size range from 25–50 µm increased (became more transparent) in the presence of 1M
NaCl when compared with both 0 M and 0.15 M NaCl. Samples of IgG1 mAb subjected to
the same shaking stress but now at pH 8 (Figure 5, right panel), in the presence of 0 M and
0.15M NaCl, contained particles with low intensity (i.e., were not transparent) and had a
high aspect ratio (i.e., more globular). Interestingly, the presence of 1 M NaCl at pH 8
caused a large increase in average intensity and a substantial reduction in the aspect ratios
for particles in the size range over 10–50 µm.
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Radar charts incorporating protein aggregate and particle formation data from multiple
analytical techniques
Radar chart array analysis was then applied to data sets from multiple analytical techniques,
which measured mAb particle and aggregate formulation over different size ranges. The
‘multiple-instruments radar chart’ was designed to provide mechanistic information relating
to the potential interrelationships of soluble aggregate and particle formation. A
representative example of the multiple-instrument radar chart is shown in Figure 6. For SEC,
Figure 6A shows a typical bar graph of SEC data for pH 6, 0.15 M NaCl mAb samples that
were heated for 2 h. SEC data includes the percent of monomer loss, soluble aggregates
formed and total area loss (i.e., loss of protein content compared to t=0 as an indirect
measure of insoluble aggregate formation). The same SEC data are also presented in radar
chart form in Figure 6D (axes 1–2 in the purple region, and axis 3 in the blue region, of the
radar chart in Figure 6D correspond to bars 1–3 in Figure 6A). Similarly for submicron
particle data, Figure 6B is a histogram of RMM data, for the same heat stressed mAb
sample, providing particle size data in the submicron range up to particles with an equivalent
spherical radius of 1.85 µm. The numbered size bins (4–6) in Figure 6B correspond to axes
4–6 in the yellow region of the corresponding radar chart (Figure 6D). Finally, Figure 6C is
a histogram of MFI particle size and concentration data for the heat stressed mAb sample for
subvisible particles of size 2–70 µm. The particle size bins numbered 7–9 in the histogram
(Figure 6C) correspond to axes 7–9 in the red region of the radar chart (Figure 6D). A more
detailed key showing the labeling of the multiple-instruments radar chart in terms of scale
and measurements, are provided in Figure 6E.
An example of utilizing a ‘multiple-instruments radar chart’ to characterize aggregate and
particle formation is shown for heat and stirring stresses of an IgG1 mAb solution at pH 6
with varying NaCl concentrations (Figure 7). At time zero (at all NaCl concentrations), the
mAb samples contained <1,000 subvisible particles, >105 submicron particles, and were >
99% monomer with <0.2% soluble aggregates. After 10 min of heat stress at 65°C, mAb
samples without NaCl showed a ~10% total peak area loss as well as a ~10% monomer loss
as measured by SEC, and after 2 h of heating, the samples had 35% total area loss, 40%
monomer loss, and 5% soluble aggregates. In addition, an extremely high concentration of
subvisible particles (>107 particles/ml) was now observed. Interestingly, under the same
conditions, the addition of 0.15 M NaCl increased soluble aggregate levels to 10% based on
SEC with a concomitant decrease the total concentration of subvisible particles by ~10 fold
as measured by MFI (and did not substantially change the amount of submicron particles).
The presence of 1 M NaCl in the mAb solution greatly increased the levels of soluble
aggregates to ~22% while the measured total area loss was approximately 20%, and the
monomer loss was ~50% as measured by SEC. In addition, the 1M NaCl containing mAb
samples showed a greatly reduced concentration of subvisible particles (<50,000 measured
by MFI), as well as a reduced concentration of submicron particles by more than 10× as
measured by RMM. After 4 h of heating, there was essentially complete aggregation and the
monomer species was virtually undetectable by SEC (left panel of Figure 7).
The effect of stirring stress on IgG1 mAb solutions is shown in the right panel of Figure 7.
In contrast to heating stress, no major changes in soluble aggregate levels with less than
10% total area loss were observed by SEC in the majority of samples subjected to stirring
stress. This result in itself suggests different aggregation mechanisms are dominant for
heating and stirring stresses. After 10 min of stirring, ~106 submicron sized particles formed
in all of the samples, and the mAb sample without NaCl had formed the most subvisible
particles ranging from 2–10 µm. After 2 and 4 h of stirring, the particle number and size
distributions in the mAb samples with 0 and 0.15 M NaCl appeared similar, but samples
with 1 M NaCl showed a ~50 fold reduction of subvisible particles along with a
substantially increased number of submicron particles (~108 particles/ml) as shown in right
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panel of Figure 7. Finally, mAb samples were shaken at pH 4 and displayed a third
dominant aggregation mechanism (See Supplemental Figure 2): no soluble aggregates were
detected by SEC, while submicron particle formation leveled off after 10 min as measured
by Archimedes. The subvisible sized particle populations continued increasing over time as
measured by MFI. Under these conditions, the addition of 1 M NaCl caused increased
formation of subvisible particles in the 25–70 µm size range.
Discussion
Utility of radar chart arrays to summarize and analyze protein aggregate and particle
formation data sets from different instruments
The ability of radar charts to better visualize protein aggregation and particle formation
results for an IgG1 mAb in different formulations, as measured by multiple analytical
instruments, was investigated in this report. We first used radar charts to examine the effect
of pH, NaCl concentration, stress type, and length of stress exposure on the size and
concentration of the sub-visible particles that were formed as measured by MFI. A broader
application of radar charts incorporating data from multiple analytical instruments was also
investigated. Radar chart array analysis was shown to be an effective tool for characterizing
the effect of individual formulation composition and environmental stress variables on
protein growth kinetics and particle size distribution. For example, the pH dependent
behavior of particle formation (number and size distribution) as a function of NaCl and
stress (i.e., shaking and stirring) was established for an IgG1 mAb. It is important to
emphasize the utility of radar charts to plot large data sets of MFI data and compare trends
across formulation conditions. For example, the MFI data in Figure 2 represents 36 different
experimental conditions (e.g., time, stress type, formulation composition) performed in
triplicate resulting in a total of 108 experiments. If histograms were to be used as shown in
Figure 1A, many plots would be needed to summarize the results and compare the effects of
time, stress type, and formulation composition on mAb particle formation (including particle
concentration and size distribution) in solution. This makes analysis of trends in particle
size, concentration and morphology more challenging. Using radar chart array analysis,
however, all of these results are displayed, and trends across the 36 conditions are
summarized in a single figure (Figure 2). The radar chart arrays in this paper were modified
to display statistical variability: the m−SD was included in the design of the concentration
vs. size radar chart to represent a lower error bar. m+SD values were used in the
morphology vs. size radar chart to maintain consistency of interpretation because it was
designed with an inverted linear axis. The ability to display the error makes these modified
radar-chart arrays a more powerful tool to study protein aggregation than other data
visualization methods that have previously been applied to study protein physical stability
such as the empirical phase diagram. It is critical for protein particle data visualization
methods to include a measure of statistical variability because protein particle measurements
often have run-to-run as well as vial-to-vial variability.6,21,23,24
Another application of radar chart analysis is to analyze the effect of formulation
composition and environmental stresses on the average morphology of any subvisible
particle size range. MFI is capable of measuring multiple particle morphological parameters
such as intensity, feret diameter, aspect ratio, circularity, etc. Unfortunately, these data
remain largely underutilized, especially in comparison to particle concentration and size
range measurements. This is largely due to unfamiliarity with the parameters and the
difficulty in presenting such large data sets in an organized fashion. Several reports have
recently presented MFI morphological data using scatter plots and line graphs.27,40 These
graphical methods are effective at presenting a few morphological data sets, however,
scatter plots and line graphs become cumbersome to interpret as the quantity of particles
and/or the number of data sets (e.g., formulation conditions and time points) increase. Other
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data visualization methods used for displaying biophysical stability data, such as the EPD,
would also be inefficient at visualizing particle morphological trends because principle
components analysis would complicate data interpretation since all of morphological
parameters correlate to varying degrees. Radar chart analysis was successful in elucidating
the effect of buffer composition (pH and NaCl concentration) and stress conditions (shaking
and stirring) on the morphology of sub-visible particles (aspect ratio and intensity) formed
from IgG1 mAb solutions (Figure 5). Radar-chart-array analysis could be applied in the
future to elucidate the effect of similar formulation variables on other particle parameters
including particle mass, reversibility (defined as a decrease in particle size when diluted to
stable pH conditions),3 density, and surface irregularity (fractal dimension); such work is
currently underway in our laboratory.
Radar chart arrays were also used to visualize results from multiple analytical instruments
that monitor protein aggregate and particle formation across size ranges from mAb soluble
aggregates (SEC), to submicron particles (RMM), and to subvisible particles (MFI). To our
knowledge, there are no other data visualization methods available which provide such a
comprehensive picture of protein aggregation data across a wide size range. Although radar
chart array analysis provided qualitative comparisons of the effect of formulation variables
on mAb aggregation, one limitation of this approach is that SEC, RMM and MFI use
different measurement methods and provide information on different numerical scales. For
example, SEC has known limitations to monitor protein aggregates including irreversible
binding of aggregates to the column matrix. In this work, an optimized SEC procedure was
utilized to minimize such issues and maximize recovery.38 In addition to loss of monomer
and increase in soluble aggregate levels, we also monitored loss of total area of samples
compared to time zero (an indirect measure of insoluble aggregate formation). RMM
measures a frequency shift caused by a particle passing through a resonator and calculates
the buoyant mass based on the shift and the sensitivity of the resonator. An equivalent
spherical diameter is calculated using the appropriate density value and the buoyant mass
(refer to Burg et al. for further explanation).41 The density of pure protein reported in the
literature is variable with values used ranging from 1.32 g/ml29 to 1.43 g/ml42. We have
chosen to use a density value of 1.41 g/ml as suggested by Fischer et al. based on the
molecular weight of IgGs.39 It is also important to mention that the Archimedes software
uses extrapolation to determine the particle concentration per ml. MFI measures the 2-
dimensional area of particles and, through image analysis, calculates the equivalent circular
diameter (ECD) of the particle.43 ECD is not directly related to spherical diameter, and
assuming such may result in an overestimation of particle volume. Another analytical
limitation in this work is the presence of a detection gap to accurately measure very small
particles from ~50 nm to 275 nm. The application of nanoparticle tracking analysis (NTA)
or dynamic light scattering would be of interest in future studies to address a more complete
size range. NTA requires, however, a high minimum concentration of submicron particles
(>106/ml) and would likely be applied to select samples. Nonetheless, radar chart analysis
was an effective tool for probing complex protein growth mechanisms monitored by
multiple analytical techniques (Figures 6 and 7) and, in general, offered the ability to more
easily follow trends in the data, thus providing some additional insights as described below.
Effects of pH, NaCl and stress on IgG1 mAb aggregate and particle formation and
morphology
The focus of this work was on the development of radar chart data visualization techniques
for MFI data on subvisible particle formation (concentration, size range, and morphology)
due to different stresses (shaking, stirring, heating). Once developed, however, interesting
trends in the physical instability of this model IgG1 mAb were readily apparent. For
example, the pH and stress-type dependence of the NaCl effect on the aggregation profile of
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this IgG1 mAb was striking. During stirring and heating, but not shaking, the presence of 1
M NaCl promoted particle growth at pH 4, but inhibited particle growth at pH 6 and 8 (refer
to Figure 7 and Supplemental Figure S3). In contrast, during shaking stress, the presence of
NaCl increased the size and concentration of particles present at pH 4, 6, and 8 (refer to
Supplemental Figure S4). This pH-dependent effect of NaCl on the physical instability of
this IgG1 mAb was also observed by separate turbidity measurements (data not shown).
Studies have previously shown that anion binding promotes aggregation of an IgG mAb
through charge shielding and by affecting conformational stability.16 In this work, the
presence of NaCl (> 0.15 M) destabilized the conformational of the mAb at pH 4 as
measured by DSC in terms of Tonset and three Tm values (See Table 1). NaCl had a much
less pronounced effect on Tonset and Tm values for this IgG1 mAb at pH 6 and 8 (See
Table 1). The observed decrease in conformational stability provides some insight into why
the presence of NaCl destabilizes this mAb at pH 4 during stress. It does not, however,
necessarily address the observed effects of NaCl on slowing particle formation during
heating or stirring at pH 6 or 8. Kroetsch et al. showed that soluble aggregates of alpha-
chymotrypsinogen A rapidly coalesce to form insoluble aggregates once a critical salt
concentration was reached.13 Our results suggest that addition of 1 M NaCl at pH 6 actually
increases the colloidal stability of this mAb since the particles formed during heating and
stirring are on average much smaller in size compared to samples with or without 0.15 M
NaCl. Accurate particle mass (or density) measurements/calculations, however, are needed
in addition to particle size, to more conclusively understand the effect of NaCl on the
colloidal stability of this mAb. Such measurements and calculations, combined with radar
chart array analysis of the results, are currently underway.
Another interesting observation is that the average morphology of subvisible particles
formed varies with solution pH and NaCl for shaking, but not stirring stress. The particles
created through stirring appear to form by a similar mechanism since they have similar size
and morphology across the pH values and NaCl concentrations as measured by MFI. In
contrast, subvisible particles created through shaking have a diverse morphology (i.e., aspect
ratio, intensity) that is sensitive to both the pH and NaCl concentration. This result suggests
that in addition to changing the conformational and colloidal stability of a mAb, the
formulation composition can also influence the mechanism of aggregation under certain
stresses, potentially by influencing the nature of the interactions between the associating
molecules.
Since formation of aggregates and particulates during long-term and accelerated stability
studies affect formulation composition choices and decisions about storage conditions and
shelf life, radar chart analysis could assist in these important comparisons during
formulation development. Stability data are also a key part of comparability assessments,
since changes in mAb drug product formulations or primary containers may affect the
protein’s physical stability.44,45 Radar charts could potentially assist in these types of
comparisons as well. For example, the effect of formulation impurities from prefilled
syringes such as silicon oil46,47 and tungsten48 on protein particle formation could be
evaluated by radar chart analysis using appropriate filters of the MFI data to separate silicon
oil droplets from protein particles.25,29
Conclusions
When conducting high throughput screening studies of protein instability under various
formulation conditions, data visualization methods are crucial to quickly and effectively
interpret large quantities of physical stability data.49,50 Radar chart analysis offers an
exciting opportunity to improve the throughput and effectiveness of analyzing protein
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aggregation and particle formation studies. Additionally, there is potential to combine
particle size/concentration data sets with more accurate measurements/approximations of
protein particle volume, partial specific volume, and mass (in development). Radar chart
analysis should also provide an improved understanding of the effect of formulation
composition and environmental stresses on the mechanisms of mAb particle formation.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Application of radar chart array analysis to evaluate subvisible particle concentration
and size distribution data measured by MFI
(a) Histogram (n=3) of representative MFI data plotting particle concentration versus
particle size (ECD) for an IgG1 mAb solution containing 20 mM citrate-phosphate buffer at
pH 8.0 and 1 M NaCl subjected to 4 hours of shaking. (b) Radar chart presentation of the
same data set; each axis is labeled with a number and is the same size range as the
corresponding numbered bin size in the histogram. The values along the each axis of the
radar chart are connected linearly to visualize the data set as a polygon. The perimeter of the
outermost polygon represents the mean particle concentration, the polygon labeled ‘mean -
SD’ represents the mean minus one standard deviation, and the distance between the
perimeters of the two polygons (along an axis) is equivalent to the lower error bar in the
equivalent bin of the histogram (one standard deviation). (c) Illustration of the particle
concentration (log scale) used in the radar charts in this work to display experimentally
measured micro flow imaging subvisible particle concentrations.
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Figure 2. Radar chart array analysis of subvisible particle concentration and size data for IgG1
mAb solutions as measured by MFI
IgG1 mAb solutions of varying pH values and NaCl concentrations were exposed to
different stress types over time as indicated in the figure (n=3), and resulting formation of
subvisible particles was measured by MFI. The Y-axis represents the amount of time the
formulations were stressed (in minutes), the X-axis represents NaCl concentrations, and
each radar chart panel (left, middle, right) signifies a change in stress or pH. See methods for
experimental details of MFI measurements from each of these accelerated stress studies.
Refer to Figure 1 for an explanation of MFI particle concentration and size range scales/
units shown in individual radar charts.
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Figure 3. Representative morphological parameters for protein particles from MFI analysis
Examples of three different aspect ratios and intensity values (low, moderate, and high) are
presented along with corresponding IgG1 mAb particle images from MFI. Model ellipses of
equivalent aspect ratios are presented to help visualize changes in particle shape. For ease of
presentation, protein particle images from MFI are not presented to scale.
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Figure 4. Application of radar chart array analysis to evaluate subvisible protein particle
morphological parameters measured by MFI
(a) Scatter plots of a subset of particle data displaying aspect ratio (top) and intensity
(bottom) versus ECD (first 3,000 from n=1 experiments) counted within an IgG1 mAb
solution containing 20 mM citrate buffer at pH 8.0 and 0.15 M NaCl subjected to 4 h of
shaking. Light red shading represents size bins with insufficient data as defined by x < 25
particles counted. (b) Radar chart presentations of the same experiment showing average
aspect ratio (top) or intensity/1000 (bottom) per size range except with the complete data set
(~200,000 particles, n=3); each numerical axis in the radar chart is an equivalent size range
to the corresponding numbered region in the scatter plots. The perimeter of the outermost
polygon displays the mean morphology parameter, the perimeter of the polygon labeled
‘mean + SD’ displays the mean plus one standard deviation, and the distance between the
perimeters of the two polygons (along an axis) is one standard deviation. (c) Illustration of
the scale/units used in the radar charts to display experimentally measured (MFI) subvisible
particle aspect ratio and intensity/1000 values.
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Figure 5. Radar chart array analysis of protein particle morphological parameters versus
particle size for IgG1 mAb solutions as measured by MFI
IgG1 mAb solutions (at indicated pH and salt concentration) were stressed to generate
protein particles (n=3), and solutions were analyzed by MFI. See methods section for
experimental details of each accelerated stress study. The Y-axis is labeled with the
morphological parameter, the X-axis represents the NaCl concentration, and each panel (left,
middle, right) represents a change in stress or pH as indicated. The numerical value/units of
each concentric circle in this radar chart is shown in Figure 4C. Light red shading represents
a region where an insufficient number of particles (x < 25) were counted. Refer to Figure 4
for an explanation of particle morphological parameters shown in individual radar charts.
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Figure 6. Application of radar chart array analysis to protein aggregate and particle formation
data from multiple analytical techniques
An IgG1 mAb solution containing 20 mM citrate phosphate buffer (pH 6.0) and 0.15 M
NaCl was heated at 65°C for 120 min and the levels of soluble aggregates, submicron and
subvisible particles were measured using SEC, RMM and MFI, respectively. (a, b, c) Bar
graph (n=3) of SEC, RMM particle concentrations (0.275–1.85 µm) and MFI particle
concentrations (2–70 µm). (d) Radar chart presentation of the same data sets shown bar
graphs (a,b,c). The SEC, RMM and MFI data denoted 1–3, 4–6 and 7–9 in the bar charts (a,
b, c, respectively) corresponds to axes 1–3, 4–6 and 7–9 in the corresponding radar chart (d).
The perimeter of the outermost polygon in the radar chart displays the mean value (particle
concentration or area gain/loss), the perimeter of the polygon labeled ‘mean - SD’ represents
the mean value minus one standard deviation, and the distance between perimeters of the
two polygons (along an axis) is one standard deviation. (e) Illustration of the numerical
scales and units for the radar chart axes with different scales being highlighted with distinct
background colors for results from SEC (1,2,3), RMM (4,5,6) and MFI (7,8,9), respectively.
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Figure 7. Radar chart analysis of protein aggregate and particle formation data from multiple
analytical techniques to visualize the extent of IgG1 physical instability
IgG1 mAb solutions containing 20 mM citrate phosphate buffer (pH 6.0) and varying NaCl
concentrations were stressed by either heat at 65°C or stirring over time (n=3). Samples
were evaluated by a combination of SEC, RMM and MFI. See methods section for
experimental details of each accelerated stress study. The Y-axis represents the amount of
time the samples was stressed (in minutes), the X-axis represents NaCl concentration, and
each radar chart panel (left and right) denotes heating and stirring, respectively. Refer to
Figure 6 for an explanation of units and scales used in the individual radar charts for each
analytical method (SEC, RMM and MFI data).
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